A follow-up study on the intrathecal synthesis of viral antibodies in multiple sclerosis patients was made on 28 patients over a period of about 2 years. Serial serum and cerebrospinal fluid specimens were assayed for antibodies against measles, rubella, parainfluenza type 2, respiratory syncytial, mumps, influenza A, influenza B, adeno, and herpes simplex viruses by employing a solid-phase enzyme immunoassay technique. All patients had local antibody synthesis against one or more of the antigens studied. Rubella and measles virus antibodies were found with the highest frequency and were synthesized at the highest rate. Simultaneous intrathecal antibody synthesis against the greater number of the viruses studied was associated with higher local immunoglobulin G synthesis. A good overall correspondence in the fluctuations of the different viral antibodies synthesized intrathecally was usually found. Sometimes the changes in intrathecal antibody levels correlated well with the changes in immunoglobulin G index and sometimes not. These fluctuations could not be correlated with the clinical course of the disease. The results of this study suggest that the viral antibodies studied are not relevant to the etiology or the pathogenesis of multiple sclerosis.
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Multiple sclerosis (MS) is a chronic relapsing and remitting neurological disease characterized by scattered lesions of myelin loss in the white matter of the central nervous system (CNS). Its cause is unknown, but epidemiological and immunological evidence tends to implicate a viral agent (21) . Immunopathological phenomena are hallmarks of this disease (2) , which suggests that autoimmunity is important for its pathogenesis.
Most MS patients synthesize immunoglobulin G (IgG) intrathecally (7, 15) . The antibody specificity of this IgG is still largely unknown. Viral antibodies studied so far seem to account for only a fraction of the bulk of the locally produced IgG (18, 34, 35) . One approach for studying the role of intrathecal antibody synthesis in the etiology and pathogenesis of MS is to examine changes in individual patients through different times and phases of the disease. Changes in synthesis rate related to the clinical course of the disease would suggest a specific role for those antibodies and corresponding antigens in the pathogenesis of MS. Few studies of this kind have been carried out, and these have not so far given clear results (1, 21, 23, 27) .
We report here a follow-up study on (31) . This study was undertaken with the patients' consent, and they were monitored for about 2 years (1977 to 1979) by one of us (M.R.). The course of the disease and details of treatment were recorded during this period. The neurological deficit value was assessed by Fog's scale (5) . Four of the patients were in the stationary phase throughout the study period, three were classified as chronic progressive, and twenty-one had a typical relapsing-remitting course of disease. At the end of the follow-up period, 5 to 15 serum-CSF specimen pairs were available per patient, totaling 217 serum-CSF specimen pairs. Specimens taken when patients were suffering a deterioration of the disease with new clinical symptoms and signs before the onset of corticotropin treatment were chosen to represent exacerbations, and specimens taken at least 3 weeks after onset of the foregoing remission represented remissions. Serial serum specimens from 11 healthy individuals (7 male and 4 female), 5 to 47 specimens from each (totaling 145 specimens), were tested for comparison. All specimens were stored at -40°C until tested.
IgG and albumin assays. The concentrations of IgG and albumin in the serum and CSF specimens were determined by the single radial immunodiffusion meth- (20) , purified hexon antigen of adenovirus type 2 (9, 26) , and virus-infected cell lysates of RSV, MV, mumps (36, 38) , influenza A, influenza B, parainfl-2 (19), and HSV (13) . The antigens were diluted in phosphate-buffered saline, pH 7.4 (PBS), and used to coat the solid phase in the following protein concentrations: rubella, 3 ,ug/ml; adenovirus, 20 ,ug/ml; MV and RSV, 10 ,ug/ml; mumps, influenza A, and influenza B viruses, 20 Fg/ml; parainfl-2, 10 ,ug/ml; and HSV, 25 37°C . After two washing cycles as above, 0.15 ml of the substrate solution consisting of 3 mg of orthophenylene diamine per ml (Koch-Light Laboratories) in 0.1 M citrate-Na2HPO4 buffer, pH 5.5, and 0.01 ml of 30o H202 per 15 ml of buffer was added. After incubation for 1 h at room temperature in the dark, the reaction was stopped by adding 0.15 ml of 1 M HCl. The intensity of the color at 492 nm was measured with a Titertek Multiscan photometer (Eflab).
The starting dilutions of the serum specimens varied from 1/200 to 1/600, and those of the CSF specimens were from 1/5 to 1/20, depending on preliminary tests. Seven twofold dilution steps were made on serum, and five were made on CSF specimens. A titration curve was drawn of each specimen, and its linear part was compared with the linear part of a twofold dilution curve of a standard serum pool (positive reference curve). The relative antibody titers were estimated by measuring the distance as the log2 from the positive reference curve (1, 12) . The corresponding serum and CSF specimens were always tested on the same plate, and the positive reference was included on every plate. All specimens from each patient or control subject were tested at the same time.
The results were expressed as the antibody index, which, according to the IgG index calculations, was defined as the CSF/serum antibody ratio divided by the CSF/serum albumin ratio. To determine the upper normal limit of the antibody index, we calculated antibody indexes for MV and RSV antibodies for 28 patients with other neurological diseases (37) . The mean plus two standard deviations were 0.49 + 0. Statistics. Spearman's rank correlation test was used to compare the IgG index and the number of elevated average antibody indexes. Ficher's exact probability test was used for comparison of changes in neurological deficit and changes in antibody indexes during the follow-up. RESULTS Intrathecal antibody synthesis in the MS patients. The average values of the IgG indexes of the patients ranged from 0.7 to 3.5. This indicated that all patients were synthesizing IgG in their CNS (32) . The CSF/serum albumin ratios showed that two patients had moderate damage in BBB with average CSF/serum albumin ratios of 0.0076 and 0.0086, and one had greater BBB damage with an average CSF/serum albumin ratio of 0.0130. One patient showed transient BBB damage.
Because many CSF-serum specimen pairs were tested per patient, every patient had many antibody index values for each antigen. The average antibody index for each antigen was the basis for assessing the intrathecal antibody synthesis. All patients had intrathecal antibody synthesis against one or more of the nine viruses studied ( found with the highest frequency and at the highest levels, closely followed by MV antibodies (Table 2 and Fig. 1 ). Those patients who had intrathecal antibody synthesis against a majority of viruses usually had higher IgG indexes than those with local antibody synthesis against only a few of the viruses studied (P < 0.01, Spearman's rank correlation test) ( Table 1) . In some patients, the intrathecal synthesis of antibodies against one or more viruses far exceeded the antibody production against the other viruses (Fig. 2) . Virus antibody synthesis during follow-up. The serum virus antibody titers were generally rather stable during the follow-up period both in the MS patients and the healthy control group (Table 3). Relatively great titer changes were occasionally observed in both groups (Table 3 ). The fluctuations were of similar magnitude for all nine virus antibodies studied. The MS patients showed slightly greater instability in serum virus antibody titers than the control subjects ( Table  3) . As there were no CSF specimens available from the control group, the follow-up study of intrathecal virus antibody synthesis was only made on the MS group. On the average, the change in antibody index to each virus from lowest to highest value was slightly less than twofold in all of the virus tests (Fig. 1) . Fourteen patients showed threefold or greater changes in antibody indexes to one or more viruses, with no particular virus being favored (Fig. 3 to 5 ). Two patients had less than a twofold change in their antibody indexes to all nine viruses (Fig. 6) . The changes in IgG index observed in the patient group during the study period were twofold or less.
The antibody indexes for the different viral antibodies showed a good overall accordance in their fluctuations (Fig. 7) . Occasionally, the levels of antibodies to one virus showed different changes from the other virus antibodies (e.g., parainfl-2 in Fig. 3 ), but these changes were not limited to any single virus. The changes in antibody indexes sometimes showed a good correlation with the changes in overall intrathecal IgG synthesis and sometimes not (Fig. 4, 5, and 7) .
Relation of intrathecal antibody synthesis to clinical findings. The intrathecal antibody synthesis during exacerbations and remissions of the disease was studied by calculating and comparing the average antibody index of specimens taken during exacerbations and remissions in the same patient. This comparison was possible for 18 patients. Three patients had an average antibody index of specimens taken during exacerbations which was higher than the average antibody index of remission specimens for all of the antibodies studied. One patient had for all of the antibodies studied an average antibody index of remissions that was higher than the average index of specimens taken during exacerbations (Fig. 4) . The majority of the patients had antibody indexes to some viruses higher in exacerbations than in remissions, and for indexes to other viruses the opposite was true.
When the levels of virus antibody indexes were monitored in each patient, fluctuations occurred both at the time of exacerbations (Fig.  4 and 5 ) and also during long periods of remission ( Fig. 4 and 7) . Exacerbations of the disease could also occur without any major change in antibody indexes (Fig. 6) . The changes in antibody indexes in the three patients with a chronic progressive course of the disease during the follow-up did not differ clearly from those of the patients with a relapsing and remitting disease course. The four patients with a stationary course of disease had relatively stable levels of intrathecal synthesis; only in one instance did the antibody index show more than a threefold change. However, the difference in the size of the patient groups made more exact comparison difficult.
The changes in antibody indexes sometimes showed a good relationship to the changes in neurological deficit (5), and sometimes they did not ( Fig. 5 and 7) . Although the changes in antibody index levels could not be related to the clinical course in individual patients, it seems that on the whole the patients with more active disease (greater changes in neurological deficit) had more changes in their intrathecal antibody synthesis. The five patients who showed over 10%o change in neurological deficit had a significantly higher frequency of threefold or greater changes in antibody index than the patients with more stable disease (P < 0.01, Fischer's exact probability test). 
DISCUSSION
The continuous intrathecal production of various viral antibodies in multiple sclerosis observed in the present study confirms earlier findings (1, 21, 27, 33) . All of the 28 patients in Intrathecal antibody synthesis against rubella and MV antigens occurred most often, which is in agreement with earlier studies (6, 22, 29) . After these, parainfl-2 and RSV antibodies were most frequently produced. Thus, we failed to confirm the observation of Vartdal et al. (35) that viruses with neurotrophic properties tend to be more frequently associated with local synthesis in the CNS in MS. HSV antibodies were synthesized at the lowest rate of the nine viral antibody types studied. This comparatively low frequency is in agreement with some earlier studies (22) , but a higher incidence of locally produced HSV antibodies has also been reported (6, 28) . All but one patient had intrathecal synthesis against some of the paramyxo-type viruses studied (MV, parainfl-2, RSV, or mumps), and all but two had intrathecal synthesis against rubella plus some of these viruses. This finding could imply a role for these viruses in the etiology of MS, but immunological hyperactivity may be a more likely explanation as fundamental defects in immunoregulation are probably present in MS (2) . MV and rubella antibodies have been shown to be elevated in peripheral blood in other diseases where immune functions are disturbed, such as systemic lupus erythematosus and chronic active hepatitis (14) . (17) . Since disease activity may not necessarily be in the same immunological phase in all parts of the brain, some discrepancies in (24) .
If intrathecal antibody synthesis against only one particular virus increases during the course of MS, it may indicate that the corresponding viral antigen is being expressed at that time locally in the brain. Such changes were observed in some of these patients. One patient showed a large increase in his already high levels of parainfl-2 antibodies in his last three specimens (Fig. 3) . Another patient (Fig. 6) (10) . This may be a valid explanation, at least for the latter patient (Fig. 6 ), because the CSF/serum albumin ratio reached 0.0070 in the second exacerbation, which is very close to the upper normal limit for the BBB integrity, whereas at other times it was about 0.0055. As mentioned above, antibodies in various parts of the brain may have different specificities (17) . Therefore, an increase in certain antibody specificities in CSF at different times may also occur after activation of different clones in different locations of the brain.
Antibody changes occurred in exacerbations and also during long remission periods, which might reflect clinically silent relapses (11) . Com 
